Epidural and intrathecal analgesia for cancer pain

Best Practice and Research: Clinical Anaesthesiology

Volumn 16, Issue 4, 2002, Pages 651-665

  Kedlaya, Divakara ^a   Reynolds, Lowell ^a   Waldman, Steven ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b Pain Consortium of Gtr Kansas City   (United States)

Author keywords

Cancer pain; Intraspinal injections; Opioids

Indexed keywords

ADENOSINE; ANALGESIC AGENT; BACLOFEN; BUPIVACAINE; CLONIDINE; DEXTROMETHORPHAN; FENTANYL; HYDROMORPHONE; KETAMINE; METHADONE; MIDAZOLAM; MORPHINE; MORPHINE SULFATE; NEOSTIGMINE; OMEGA CONOTOXIN MVIIA; OPIATE; PETHIDINE; PHYSOSTIGMINE; ROPIVACAINE; SOMATOSTATIN; SUFENTANIL; TETRACAINE; TIZANIDINE; VERAPAMIL; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMINO ACID RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; LOCAL ANESTHETIC AGENT; NARCOTIC ANALGESIC AGENT;

ARTICLE; ATAXIA; BRADYCARDIA; CANCER PAIN; CARDIOVASCULAR DISEASE; CEREBROSPINAL FLUID FISTULA; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONVULSION; COST EFFECTIVENESS ANALYSIS; DIZZINESS; DRUG APPROVAL; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG TOLERANCE; EDEMA; EPIDURAL ANESTHESIA; FATIGUE; FOOD AND DRUG ADMINISTRATION; HEADACHE; HUMAN; HYGROMA; HYPERALGESIA; HYPOTENSION; IMPOTENCE; INJECTION PAIN; LETHARGY; LIBIDO DISORDER; LIQUORRHEA; MENINGITIS; MICTURITION DISORDER; MUSCLE WEAKNESS; MYOCLONUS; NAUSEA; NAUSEA AND VOMITING; NEUROTOXICITY; NIGHTMARE; NONHUMAN; NYSTAGMUS; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; SEDATION; SEROMA; SOMNOLENCE; SPINAL ANESTHESIA; SPINAL CORD DISEASE; SWEAT GLAND DISEASE; UNITED STATES; URINE RETENTION; VOMITING; WITHDRAWAL SYNDROME; WORLD HEALTH ORGANIZATION; XEROSTOMIA; INTRASPINAL DRUG ADMINISTRATION; METHODOLOGY; NEOPLASM; PAIN; REVIEW;

ADRENERGIC ALPHA-AGONISTS; ANALGESIA, EPIDURAL; ANALGESICS, OPIOID; ANESTHETICS, LOCAL; CALCIUM CHANNEL BLOCKERS; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; INJECTIONS, SPINAL; NEOPLASMS; PAIN;

EID: 0036977667     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1053/bean.2002.0253     Document Type: Article

References (83)

1. Yaksh TL, Rudy TA. Analgesia mediated by a direct spinal action of narcotics Science 192 1976 1357-1358
2. Wang JK, Naus LA, Thomas JE. Pain relief by intrathecally applied morphine in man Anesthesiology 50 1979 149-151
3. Behar M, Olshwang D, Magora F, Davidson JT. Epidural morphine in treatment of pain Lancet i 1979 527-528
4. Ventafridda V, Fighuzzi M, Tamburini M et al. Clinical observation on analgesia elicited by intrathecal morphine in cancer patients In Bonica JJ, & Ventafridda V. (eds.), Advances in Pain Research and Therapy 1979 559-565 Raven Press New York
5. Cousins MJ, Mather LE, Glynn CJ. et al. Selective spinal analgesia Lancet i 1979 1141-1142
6. Rico RC, Hobica GH, Avellanosa AM. Use of intrathecal and epidural morphine for pain relief in patients with malignant disease: a preliminary report Journal of Medicine 13 1982 223-231
7. Lazorthes Y, Siegfraied J, Gouarderes C et al. Periventricular gray matter stimulation versus chronic intrathecal morphine in cancer pain Advances in Pain Research and Therapy 5 1983 467-475
8. Coombs DW, Maurer LH, Saunders RL, Gaylor M. Outcomes and complications of continuous intraspinal narcotic analgesia for cancer pain control Journal of Clinical Oncology 2 1984 1414-1420
9. Penn RD, Paice JA, Gottschalk W, Ivankovich AD. Cancer pain relief using chronic morphine infusion. Early experience with a programmable implanted pump Journal of Neurosurgery 61 1984 302-306
10. Cobb CA III, French BN, Smith KA. Intrathecal morphine for pelvic and sacral pain caused by cancer Surgical Neurology 22 1984 63-68
11. Krames ES, Gershow J, Glassberg A et al. Continuous infusion of spinally administered narcotics for relief of pain due to malignant disorders Cancer 56 1985 696-702
12. Wang JK, Intrathecal morphine for intractable pain secondary to cancer of pelvic organs Pain 21 1985 99-102
13. Shetter AG, Hadley MN, Wilkinson E. Administration of intraspinal morphine sulfate for the treatment of intractable cancer pain Neurosurgery 18 1986 740-747
14. Ventafridda V, Spoldi V, Caraceni A. DeConno F Intraspinal morphine for cancer pain Acta Anaesthesiologica Scandinavica 85 (supplement) 1987 47-53
15. Penn RD, Paice JA. Chronic intrathecal morphine for intractable pain Journal of Neurosurgery 67 1987 182-187
16. Madrid JL, Fatela LV, Lobato RD, Gozalo A. Intrathecal therapy: rationale, technique, clinical results Acta Anaesthesiologica Scandinavica 85 (supplement) 1987 60-67
17. Brazenor GA. Long term intrathecal administration of morphine: a comparison of bolus injection via reservoir with continuous infusion by implanted pump Neurosurgery 21 1987 484-491
18. Onofrio BM, Yaksh TL. Long-term pain relief produced by intrathecal morphine infusion in 53 patients Journal of Neurosurgery 72 1990 200-209
19. Hassenbusch SJ, Pillay PK, Magdinec M et al. Constant infusion of morphine for intractable cancer pain using an implanted pump Journal of Neurosurgery 73 1990 405-409
20. Plummer JL, Cherry DA, Cousins MJ et al. Long-term spinal administration of morphine in cancer and non-cancer pain: a retrospective study Pain 44 1991 215-220
21. Anderson PE, Coher JI, Everts EC et al. Intrathecal narcotics for relief of pain from head and neck cancer Archives of Otolaryngology and Head and Neck Surgery 117 1991 1277-1280
22. Waterman NG, Hughes S, Foster WS. Control of cancer pain by epidural infusion of morphine Surgery 110 1991 612-614
23. Follett KA, Hitchon PW, Piper J et al. Response of intractable pain to continuous intrathecal morphine: a retrospective study Pain 49 1992 21-25
24. Schultheiss R, Schramm J, Neidhardt J. Dose changes in long- and medium term intrathecal morphine therapy of cancer pain Neurosurgery 31 1992 664-669
25. Chambers FA, MacSullivan R. Intrathecal morphine in the treatment of chronic intractable pain Irish Journal of Medical Science 163 1994 318-321
26. Devulder J, Ghys L, Dhondt W, Rolly G. Spinal analgesia in terminal care: risk versus benefit Journal of Pain and Symptom Management 9 1994 75-81
27. Paice JA, Penn RD, Shott S. Intraspinal morphine for chronic pain: a retrospective, multicenter study Journal of Pain and Symptom Management 11 1996 71-80
28. Erdine SS, Yucel A. Intrathecal morphine delivered by implanted manual pump for cancer pain Pain Digest 6 1996 161-165
29. Ballantyne JC, Carr DB, Berkey CS et al. Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer Regional Anesthesia 21 1996 542-556
30. Gestin Y, Vainio A, Pegurier AM. Long-term intrathecal infusion of morphine in the home care of the patients with advanced cancer Acta Anaesthesiologica Scandinavica 41 1997 12-17
31. Smitt PS, Tsafka A, Teng-van-de-Zande F et al. Outcome and complications of epidural analgesia in patients with chronic cancer pain Cancer 83 1998 2015-2022
32. Sallerin-Caute B, Lazorthes Y, Deguine O et al. Does intrathecal morphine in the treatment of cancer pain induce the development of tolerance? Neurosurgery 42 1998 44-49
33. Gilmer HS, Boggan JE, Smith KA et al. Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer Surgical Neurology 51 1999 6-11
34. Dougherty PM, Staats PS, Intrathecal drug therapy for chronic pain: from basic science to clinical practice Anesthesiology 91 1999 1891-1918
35. Wallace M, Yaksh TL. Long-term spinal analgesic delivery: a review of the preclinical and clinical literature Regional Anesthesia and Pain Medicine 25 2000 117-157
36. Krames ES. Intrathecal infusional therapies for intractable pain: patient management guidelines Journal of Pain and Symptom Management 8 1993 36-46
37. Crul BJ, Delhaas EM. Technical complications during longterm subarachnoid or epidural administration of morphine in terminally ill cancer patients: a review of 140 cases Regional Anesthesia 16 1991 209-213
38. Mercadante S, Agnello A, Armata MG, Purno S. The inappropriate use of the epidural route in cancer pain Journal of Pain and Symptom Management 13 1997 233-237
39. Aldrete JA. Epidural fibrosis after permanent catheter insertion and infusion Journal of Pain and Symptom Management 10 1995 624-631
40. Appelgren L, Nordberg C, Sjoberg M et al. Spinal epidural metastasis: Implications for spinal analgesia to treat 'refractory' cancer pain Journal of Pain and Symptom Management 13 1997 25-42
41. Schuchard M, Lanning R, North R et al. Neurologic sequelae of intraspinal drug delivery systems: Results of a survey of American implanters of implantable drug delivery systems Neuromodulation 1 1998 137-148
42. Rawal N. Spinal opioids In Raj PP (ed.), Practical Management of Pain 1999 829-851 Mosby Year Book St Louis
43. Gourlay GK, Plummer JL, Cherry DA et al. Comparison of intermittent bolus with continuous infusion of epidural morphine in the treatment of severe cancer pain Pain 47 1991 135-140
44. Hassenbusch SJ, Paice JA, Patt RB et al. Clinical realities and economic considerations: economics of intrathecal therapy Journal of Pain and Symptom Management 14(Supplement) 1997 36-48
45. McQuay HJ, Sullivan AF, Smallman K, Dickenson AH. Intrathecal opioids, potency and lipophilicity Pain 36 1989 111-115
46. Nitescu P, Sjoberg M, Applegren L, Curelaru I. Complications of intrathecal opioids and bupivacaine treatment of refractory cancer pain Clinical Journal of Pain 11 1995 45-62
47. Wagemans MF, van der Valk P, Spoelder EM et al. Neurohistopathological findings after continuous intrathecal administration of morphine or a morphine/bupivacaine mixture in cancer pain patients Acta Anaesthesiologica Scandinavica 41 1997 1033-1038
48. Sjoberg M, Karlsson PA, Nordborg C et al. Neuropathologic findings after longterm intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients Anesthesiology 76 1992 173-186
49. Krames ES, Lanning RM. Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine Journal of Pain and Symptom Management 8 1993 539-548
50. Sjoberg M, Nitescu P, Appelgren L, Curelaru I. Long term intrathecal morphine and bupivacaine in patients with refractory cancer pain. Results from a morphine:bupivacaine dose regimen of 0.5:4.75 mg/ml Anesthesiology 80 1994 284-297
51. Boogaerts JG, Lafont ND, Declercq AG, Epidural administration of liposome-associated bupivacaine for the management of postsurgical pain: a first study Journal of Clinical Anesthesiology 6 1994 315-320
52. Markham A, Faulds D, Ropivacaine: a review of its pharmacology and therapeutic use in regional anesthesia Drugs 52 1996 429-449
53. Scott DA, Emanuelsson BM, Mooney PH et al. Pharmacokinetics and efficacy of long-term epidural ropivacaine infusion for postoperative analgesia Anesthesia & Analgesia 85 1997 1322-1330
54. Howe JR, Yaksh TL. Characterization of (3H)rauwolscine binding to alpha 2-adrenoceptor sites in the lumbar spinal cord of the cat: Comparison to such binding sites in the cat frontal cerebral cortex Brain Research 368 1986 87-100
55. Bouchenafa O, Livingston A. Autoradiographic localization of alpha 2 adrenoceptor binding sites in the spinal cord of the sheep Research in Veterinary Science 42 1987 382-386
56. Ono H, Mishima A. Ono S et al. Inhibitory effects of clonidine and tizanidine on release of substance P from slices of rat spinal cord and antagonism by alpha-adrenergic receptor antagonists Neuropharmacology 30 1991 585-589
57. Eisenach JC, Dewan DM, Rose JC, Angelo JM. Epidural clonidine produces antinociception, but not hypotension, in sheep Anesthesiology 66 1987 496-501
58. Eisenach J, Detweiler D, Hood D. Hemodynamic and analgesic actions of epidurally administered clonidine Anesthesiology 78 1993 277-287
59. Naguib M, Yaksh TL. Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with μ and α2 receptor systems Anesthesiology 80 1994 1338-1348
60. Hood DD, Mallak KA, Eisenach JC, Tong CY. Interaction between intrathecal neostigmine and epidural clonidine in human volunteers Anesthesiology 85 1996 315-325
61. De Kock M, Eisenach J, Tong C et al. Analgesic doses of intrathecal but not intravenous clonidine increase acetylcholine in cerebrospinal fluid in humans Anaesthesia & Analgesia 84 1997 800-803
62. Coombs DW, Saunders RL, Fratkin JD et al. Continuous intrathecal hydromorphone and clonidine for intractable cancer pain Journal of Neurosurgery 64 1986 890-894
63. Eisenach JC, Rauck RL, Buzanell C, Lysak SZ. Epidural clonidine analgesia for intractable cancer pain: phase 1 Anesthesiology 71 1989 647-652
64. Eisenach JC, DuPen S, Dubois M et al. Epidural clonidine analgesia for intractable cancer pain Pain 61 1995 391-399
65. Tumber PS, Fitzgibbon DR. The control of severe cancer pain by continuous intrathecal infusion and patient controlled intrathecal analgesia with morphine, bupivacaine and clonidine Pain 78 1998 217-220
66. Portas M, Marty JY, Buttin C et al. Refractory pain in children with cancer: role of peridural analgesia Archives of Pediatrics 5 1998 851-860
67. Eisenach JC, Tong C. Site of hemodynamic effects of intrathecal alpha-2 adrenergic agonists Anesthesiology 74 1991 766-771
68. Correa-Sales C, Rabin BC, Maze M. A hypnotic response to dexmedetomidine, an alpha-2 agonist, is mediated in the locus coeruleus in rats Anesthesiology 76 1992 948-952
69. Mitchell JJ, Anderson KJ. Quantitative autoradiographic analysis of excitatory amino acid receptors in the cat spinal cord Neuroscience Letters 124 1991 269-272
70. Sato K, Kiyama H, Park HT, Tohyama M. AMPA, KA, and NMDA receptors are expressed in the rat DRG neurons Neuroreport 4 1993 1263-1265
71. Chapman V, Dickinson AH. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn Brain Research 573 1992 321-323
72. Yang CY, Wong CS, Chang JY. Ho ST. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain Canadian Journal of Anaesthesiology 43 1996 379-383
73. Karpinski N, Dunn J, Hansen L. Masliah E Subpial vacuolar myelopathy after intrathecal ketamine: report of a case Pain 73 1997 103-105
74. Wang YX, Bowersox SS. Analgesic properties of ziconotide, a selective blocker of N-type neuronal calcium channels CNS Drug Review 6 2000 1-20
75. Jain KK. An evaluation of intrathecal ziconotide for the treatment of chronic pain Expert Opinion in Investigative Drugs 9 2000 2403-2410
76. Atanassoff PG, Hartmannsgruber MW, Thrasher J et al. Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain Regional Anesthesia and Pain Medicine 25 2000 274-278
77. Mayo, M, Ellis, D, J, Analgesic efficacy of intrathecal ziconotide in common painful conditions. Abstract, Worldwide Pain Conference, San Francisco, CA, USA, July 19, 2000.
78. Penn RD, Paice JA. Adverse effects associated with the intrathecal administration of ziconotide Pain 85 2000 291-296
79. Mollenholt P, Rawal N, Gordh T Jr, Olsson Y. Intrathecal and epidural somatostatin for patients with cancer. Analgesic effects and postmortem neuropathologic investigations of spinal cord and nerve roots Anesthesiology 81 1994 534-542
80. Borg PA, Krijnen HJ. Long-term intrathecal administration of midazolam and clonidine Clinical Journal of Pain 12 1996 63-68
81. Erdine S, Yucel A, Ozalcin S et al. Neurotoxicity of midazolam in the rabbit Pain 80 1999 419-423
82. Rane K, Sollevi A, Segerdahl M. Intrathecal adenosine administration in abdominal hysterectomy lacks analgesic effect Acta Anaesthesiologica Scandinavica 44 2000 868-872
83. Tan P-H, Kuo J-H, Liu K et al. Efficacy of intrathecal neostigmine for the relief of postinguinal hemiorrhaphy pain Acta Anaesthesiologica Scandinavica 44 2000 1056-1060